Search results for "medicaments"

showing 10 items of 43 documents

Lack of Functional Trehalase Activity in Candida parapsilosis Increases Susceptibility to Itraconazole

2022

Central metabolic pathways may play a major role in the virulence of pathogenic fungi. Here, we have investigated the susceptibility of a Candida parapsilosis mutant deficient in trehalase activity (atc1Δ/ntc1Δ strain) to the azolic compounds Fluconazole and Itraconazole. A time-course exposure to Itraconazole but not Fluconazole induced a significant degree of cell-killing in mutant cells compared to the parental strain. Flow cytometry determinations indicated that Itraconazole was able to induce a marked production of endogenous ROS together with a simultaneous increase in membrane potential, these effects being irrelevant after Fluconazole addition. Furthermore, only …

Microbiology (medical)Medicaments antifúngicsbiology_otherPlant ScienceFongs patògensfluconazole; itraconazole; ROS; mitochondrial activity; trehalase; trehalose; <i>Candida parapsilosis</i>Ecology Evolution Behavior and Systematics
researchProduct

Documento de consenso sobre el tratamiento antimicrobiano de las infecciones bacterianas odontogénicas

2005

Las infecciones de la cavidad bucal son un problema de salud pública frecuente y motivo constante de prescripción antibiótica; el 10% de los antibióticos se emplean para tratar este problema. Sin embargo, hasta la fecha son pocos los estudios realizados para determinar su incidencia. Asímismo, su relación con ciertas enfermedades sistémicas (cardiacas, endocrinas, etc...) confiere a estas patologías una importancia vital. A pesar de la reconocida frecuencia e importancia de las infecciones odontogénicas, llama la atención la actual dispersión de criterio en varios aspectos referentes a su clasificación, terminología y recomendaciones terapéuticas. El objetivo principal de este documento, re…

MicroorganismosEfecte dels medicaments sobre els microorganismes:CIENCIAS MÉDICAS ::Ciencias clínicas::Otras [UNESCO]Bacterial diseasesMicroorganismsAntibiòticsOral medicineMicroorganismesMouth MicrobiologyClasificaciónMalalties de la bocaInfectionsAmoxicilina/ácido clavulánicoAntibioticsResistenciaTratamientoMicrobiologia dentalOdontogénicosAntibióticosInfecciones odontogénicas; Clasificación; Diagnóstico; Tratamiento; Microorganismos; Odontogénicos; Resistencia; Antimicrobianos; Antibióticos; Amoxicilina/ácido clavulánicoGeneral DentistryAntimicrobianosMouthMalalties bacterianesUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::OtrasBocaDiagnósticoInfecciones odontogénicasInfeccionsMouth diseasesOtorhinolaryngologyEstomatologiaEffect of drugs on microorganisms
researchProduct

Adverse side effects of statins in the oral cavity

2008

Podeu consultar la versió en castellà a http://hdl.handle.net/2445/117363

Mouth diseasesEfectes secundaris dels medicamentsSymptomsUNESCO::CIENCIAS MÉDICASDrug side effectslipids (amino acids peptides and proteins)HipercolesterolèmiaHypercholesteremiaMalalties de la boca:CIENCIAS MÉDICAS [UNESCO]Símptomes
researchProduct

The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

2021

Introduction: The role of Olanzapine therapeutic drug monitoring is controversial. The present study explores the associations of Olanzapine plasma concentrations with clinical response and metabolic side effects in first episode psychosis (FEP) after 2 months of treatment. Methods: Forty-seven patients were included. Improvement in clinical symptomatology was assessed using the PANSS. Metabolic assessment included weight, blood pressure, waist circumference, blood glucose, total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglycerides. Results: The Olanzapine plasma concentrations after 2 months of treatment were positively correlated with weight gain (r = 0.49, p …

OlanzapineAdultBlood GlucoseMalemedicine.medical_specialtyFarmacologiaWaistBlood PressureWeight GainGastroenterology03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicinemedicineHumansPharmacologyValproic Acidmedicine.diagnostic_testbusiness.industrySmokingMiddle Aged030227 psychiatryBlood pressureTreatment OutcomePsychotic DisordersTherapeutic drug monitoringOlanzapineFemalemedicine.symptomDrug MonitoringbusinessWeight gain030217 neurology & neurosurgeryMedicamentsLipoproteinmedicine.drugAntipsychotic Agents
researchProduct

Galenisme i medicaments en els sermons de sant Vicent Ferrer

2021

The sources inspiring the sermons of Saint Vincent Ferrer have been investigated in many studies. Yet, research on how the Valencian preacher used science and medicine to explain to his audience the contents of theology have scarcely been published. The sermons of Saint Vincent Ferrer are filled with aspects related to health and disease, therapies and their practitioners. Galenism appears constantly, being the leading medical system during that time. In this case we will focus on drugs as a homiletic resource, as a widespread therapy and, therefore, a comprehensible aspect for the audience. This approach will lead us, not only to further understand the resources of the preacher, but also t…

SermonsPredicacióMedicaments
researchProduct

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) …

2017

Background HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. Primary study objectives were assessment of efficacy and safety of simeprevir plus PR in treatment-naïve patients with HCV GT4 treated for 12 weeks. Primary efficacy outcome was sustained virologic response 12 weeks post-treatment (SVR12). Additional objectives included investigation of potential associations of rapid virologic response and baseline factors with SVR12. Methods This multicentre, open-label, single-arm study (NCT01846832) evaluated efficacy and safety of simepre…

SimeprevirMalePsychologie appliquéeFetge - MalaltiesHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycols0302 clinical medicinelcsh:Science61 - MedicinaLiver DiseasesSciences bio-médicales et agricolesCirrhosisInterferonLiver Fibrosis030211 gastroenterology & hepatologyDrug Therapy CombinationViral loadBiologieHumanmedicine.medical_specialtyCiències multidisciplinàriesGenotypeSaudi ArabiaAlpha interferon:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Gastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesHumansAgedMedicine and health sciencesHepaciviruFlavivirusesInterleukinslcsh:ROrganismsInterleukinmedicine.diseaseRegimen:Digestive System Diseases::Liver Diseases [DISEASES]chemistryImmunologylcsh:QMedicaments - AdministracióDevelopmental BiologyRNA viruseslcsh:Medicinemedicine.disease_cause:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Geographical Locationschemistry.chemical_compoundSimeprevirHospital Universitari Vall d’Hebron030212 general & internal medicinePathology and laboratory medicineMultidisciplinaryHepatitis C virusHepatitis CRecombinant ProteinMedical microbiologyMiddle AgedViral LoadHepatitis CRecombinant Proteins:enfermedades del sistema digestivo::enfermedades hepáticas [ENFERMEDADES]EuropeResearch DesignVirusesFemalePathogensResearch ArticleAdultAsiaAdolescentClinical Research DesignHepatitis C virusResearch and Analysis MethodsYoung AdultInternal medicineRibavirinmedicineddc:610Rapid Virologic ResponseAntiviral AgentBiology and life sciencesbusiness.industryRibavirinViral pathogensInterferon-alphaFibrosisHepatitis virusesMicrobial pathogensPeople and PlacesAdverse EventsInterferonsbusinessPLoS ONE
researchProduct

Mediterranean Diet and Physical Activity Decrease the Initiation of Cardiovascular Drug Use in High Cardiovascular Risk Individuals: A Cohort Study

2021

Our aim was to assess whether long-term adherence to a Mediterranean diet (MedDiet) and leisure-time physical activity (LTPA) were associated with a lower initiation of cardiovascular drug use. We studied the association between cumulative average of MedDiet adherence and LTPA and the risk of cardiovascular drug initiation in older adults at high cardiovascular risk (PREvención con DIeta MEDiterránea trial participants) non-medicated at baseline: glucose-lowering drugs (n = 4437), antihypertensives (n = 2145), statins (n = 3977), fibrates (n = 6391), antiplatelets (n = 5760), vitamin K antagonists (n = 6877), antianginal drugs (n = 6837), and cardiac glycosides (n = 6954). One-point increas…

StatinMediterranean dietPhysiologymedicine.drug_classClinical Biochemistryphysical activityFibrateantiplatelet drugs030204 cardiovascular system & hematologyPharmacologyLower riskBiochemistryMetabolic equivalentArticlestatinscardiac glycosides03 medical and health sciences0302 clinical medicineMediterranean cookingMediterranean dietCuina mediterràniamedicine030212 general & internal medicinevitamin K epoxide reductase inhibitorsMolecular BiologyCardiac glycosideglucose-lowering drugsbusiness.industrylcsh:RM1-950mediterranean dietCell BiologyVitamin K antagonistPhysical fitnessCardiovascular agentslcsh:Therapeutics. Pharmacologyantihypertensive drugsantianginal drugsfibratesbusinessCohort studymedicine.drugCondició físicaMedicaments cardiovasculars
researchProduct

Informació economicofinanceraen l’empresa farmacèutica

2019

En aquest tema es descriu a nivell bàsic la comptabilitat i els comptes anuals, on l'estudiant ha de saber llegir els comptes anuals. Es revisen ràtios bàsics de comptabilitat i s'estudia el marge brut i el punt d'equilibri. D'altra banda s'ensenya a l'alumne a calcular els preus dels medicaments inclosos imposats i recàrrec d'equivalència.

finançamentbalanç i ràtiosimpostos i règim fiscalpreus de medicamentscomptabilitatUNESCO::CIENCIAS ECONÓMICASrendibilitatcomptes anuals
researchProduct

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

2020

[This corrects the article DOI: 10.3389/fimmu.2019.01151.].

lcsh:Immunologic diseases. Allergycritical limb ischemiamedicine.medical_specialtyclinical trialsdiabetesbusiness.industrycost-effectivecell-based therapyImmunologyType 2 Diabetes MellitusCorrectionCritical limb ischemiamedicine.diseasecellular medicamentsCell therapyClinical trialDiabetes mellitusInternal medicinemedicineImmunology and Allergymedicine.symptombusinesslcsh:RC581-607
researchProduct

Association of burning mouth syndrome with xerostomia and medicines

2005

Objetivo: Identificar factores de riesgo para el síndrome de boca ardiente (SBA) a través de estudio de casos y controles. Material y métodos: Se realizó análisis cuantitativo del flujo salival total en reposo y estimulado; se registraron la xerostomía subjetiva, el consumo de medicamentos y los estados psicológicos de ansiedad y depresión en 40 pacientes con SBA y 40 controles. Resultados: El análisis ANOVA mostró diferencias significativas en las medias del número de medicamentos/día, número de medicamentos xerostomizantes/día, xerostomía subjetiva, ansiedad y depresión, entre los grupos estudiados. No se observaron diferencias significativas en las tasas de flujo salival en reposo y esti…

medicamentosEfecte dels medicaments sobre els microorganismeshiposalivaciónOdontologíaMalalties de la boca:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludxerostomíaMouth diseasesUNESCO::CIENCIAS MÉDICASEffect of drugs on microorganismsflujo salivalSíndrome de boca ardienteSaliva
researchProduct